Collegium Pharmaceutical (COLL) Other financing activities (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Other financing activities of $947000.0 for Q1 2026, down 38.98% year-over-year from $1.6 million in Q1 2025, and down 67.54% quarter-over-quarter from $2.9 million in Q4 2025.
Collegium Pharmaceutical (COLL) Other financing activities (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Other financing activities history runs 13 years deep, the most recent figure standing at $947000.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 38.98% year-over-year to $947000.0; the TTM figure through Mar 2026 stood at $3.7 million (up 81.66% YoY), while the FY2025 annual figure was $4.3 million, up 417.53% from the prior year.
- Other financing activities for Q1 2026 stood at $947000.0, down from $2.9 million in the prior quarter.
- The five-year high for Other financing activities was $9.6 million in Q2 2024, with the low at -$9.2 million in Q4 2024.
- The 5-year median for Other financing activities is $356000.0 (2024), against an average of $1.0 million.
- The sharpest annual moves came in 2022 and 2025: Other financing activities sank 433.76% in 2022, then jumped 335.96% in 2025.
- Collegium Pharmaceutical's Other financing activities stood at -$4.5 million in 2022, then jumped by 172.5% to $3.2 million in 2023, then slumped by 385.37% to -$9.2 million in 2024, then jumped by 131.55% to $2.9 million in 2025, then plunged by 67.54% to $947000.0 in 2026.
- Business Quant data shows COLL's Other financing activities at $947000.0 in Q1 2026, $2.9 million in Q4 2025, and -$497000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Collegium Pharmaceutical | 887.48 Mn | 738.16 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 947,000.00 |
| Mar 31, 2026 | 947,000.00 |
| Dec 31, 2025 | 2.92 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | -497,000.00 |
| Sep 30, 2025 | -497,000.00 |
| Jun 30, 2025 | 308,000.00 |
| Jun 30, 2025 | 308,000.00 |
| Mar 31, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | -9.25 Mn |
| Dec 31, 2024 | -9.25 Mn |
| Sep 30, 2024 | 149,000.00 |
| Sep 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 9.57 Mn |
| Jun 30, 2024 | 9.57 Mn |
| Mar 31, 2024 | 356,000.00 |
| Mar 31, 2024 | 356,000.00 |
| Dec 31, 2023 | 3.24 Mn |
| Dec 31, 2023 | 3.24 Mn |